Ok. As long as Market cap on total outstanding shares Class A + Class B is around $1B I don't see why they wouldn't approach $9 pps. Other than a discount for bankruptcy and dividends.
Im thinking dividends will come from excellagen and NGIO doesn't own that.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links